Nexpoint Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Nexpoint Asset Management's CCXI Position: Q4 2022 in Review
Nexpoint Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 1,315,094 shares — an estimated $67.9M sold.
Nexpoint Asset Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $67.9M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Nexpoint Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Nexpoint Asset Management sold 1,315,094 ChemoCentryx, Inc. shares in Q4 2022, an estimated $67.9M.
- Nexpoint Asset Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
- Nexpoint Asset Management's ChemoCentryx, Inc. position peaked at $67.9M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Nexpoint Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.